# The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

> **NCT02387359** · PHASE3 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 1054 (actual)

## Conditions studied

- Irritable Bowel Syndrome Characterized by Constipation

## Interventions

- **DRUG:** Plecanatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02387359
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2016-12
- **Final completion:** 2017-02
- **Target enrollment:** 1054 (ACTUAL)
- **Last updated:** 2019-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02387359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02387359, "The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02387359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*